Blood filtering therapy shows promise for MS in small trial
Disease control
Completed
This study tested a treatment called extracorporeal photopheresis (ECP) in 15 people with multiple sclerosis (MS). ECP involves taking blood, treating it with light and a drug, then returning it to the body. The goal was to see if it is safe and might help improve walking, hand f…
Phase: PHASE1, PHASE2 • Sponsor: Abu Dhabi Stem Cells Center • Aim: Disease control
Last updated May 08, 2026 12:04 UTC